FDA Inspection 1267026 — Sunsho Pharmaceutical Co., Ltd.

Sunsho Pharmaceutical Co., Ltd. — FEI 3010314763

The FDA completed an inspection of Sunsho Pharmaceutical Co., Ltd. on April 17, 2025 in Fuji. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 7 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
April 17, 2025
Fiscal Year
2025
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Fuji (Japan)

Citations

IDCFRDescription
1570221 CFR 111.320(b)Examination, testing; scientifically valid
1578521 CFR 111.410(b)Label, packaging - discrepancies
2284321 CFR 111.70(b)Specifications - components
2284721 CFR 111.70(e)Specifications - finished dietary supplement
2288521 CFR 111.205(a)Master manufacturing record - followed
2288821 CFR 111.210Master manufacturing record - record requirements
2289021 CFR 111.260Batch record - required information